From promise to people.

At Lineage, our mission is to pioneer a new branch of medicine based on transplanting specific cell types to patients with serious medical conditions

Our
Pipeline

Company
Presentation

Genentech and Lineage are working together to expand benefits of cell therapy to eye diseases

We’re teaming up to create allogeneic retinal pigment epithelial (RPE) cells to either replace or support cells that are dysfunctional or absent due to degenerative disease

In the Media

View more media

OPC1 Patient Spotlight

Sonia’s OpRegen Story

News and Events

View more news and events

Mar 09, 2023 – Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Feb 08, 2023 – Lineage Provides Update on Auditory Neuronal Cell Transplant Program for the Treatment of Hearing Loss

Recent Financials

Listen to our 4^th Quarter 2022
Earnings Call